Replies to post #213223 on Biotech Values

[biomaven0]

>>What do you think of the risk/reward for FGEN now?

It's by far my biggest personal holding, and that reflects my own judgement on its long-term prospects. I really don't think analysts have grasped how big the potential for roxa is provided safety is good, and I also don't think they fully grasp the Chinese opportunity given an estimated 120 million Chinese CKD patients (but only a portion of these have anemia that needs treatment).

Chances are they will report some deaths in the 1-year dialysis safety study in China - this is a population with an expected high death rate. So no idea if market will freak out at that.